CBIO — Crescent Biopharma, Inc. stock price, charts and financials

QT50Crescent Biopharma, Inc.

Crescent Biopharma, Inc. (NASDAQ: CBIO) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
16.38
+1.51+10.15%
OverviewShort InterestFilings
CBIOQT50Crescent Biopharma, Inc.·NASDAQ
16.38+10.15%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Aug 04, 20263Initial statement of beneficial ownership
Aug 04, 20264Statement of changes in beneficial ownership
Aug 04, 20264Statement of changes in beneficial ownership
Aug 04, 20263Initial statement of beneficial ownership
Aug 03, 2026EFFECTNotice of effectiveness
Jul 31, 2026EFFECTNotice of effectiveness
Jul 30, 2026424B3Prospectus
Jul 30, 20268-KCurrent report
Jul 30, 202610-QQuarterly report
Jul 30, 2026POS AMPost-effective amendment
Jul 20, 20264Statement of changes in beneficial ownership
Jul 20, 2026SC 13D/ABeneficial ownership statement (active, amended)
Jul 16, 20268-KCurrent report
Jul 15, 2026424B5Prospectus
Jul 15, 20268-KCurrent report
Jul 15, 20268-K/ACurrent report (amended)
Jul 14, 2026424B5Prospectus
Jul 14, 20268-KCurrent report
Jul 13, 2026S-3/AShelf registration statement (amended)
Jul 10, 2026EFFECTNotice of effectiveness
Jul 01, 2026S-3Shelf registration statement
Jun 30, 20264Statement of changes in beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
#1 / 25 of 538
Page
▼
/ 22